| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-CD20-IL-21 fusokine: the tail wags the dog
|
Ansell, Stephen M.
|
|
|
129 |
16 |
p. 2209-2210
|
artikel
|
| 2 |
Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell–dependent cytotoxicity
|
Bhatt, Shruti
|
|
|
129 |
16 |
p. 2246-2256
|
artikel
|
| 3 |
Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial
|
Zinzani, Pier Luigi
|
|
|
129 |
16 |
p. 2328-2330
|
artikel
|
| 4 |
Complement and clot
|
Afshar-Kharghan, Vahid
|
|
|
129 |
16 |
p. 2214-2215
|
artikel
|
| 5 |
Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development
|
Subramaniam, Saravanan
|
|
|
129 |
16 |
p. 2291-2302
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
129 |
16 |
p. i
|
artikel
|
| 7 |
Efficacy in the margins of NHL with ibrutinib
|
Barr, Paul M.
|
|
|
129 |
16 |
p. 2207-2208
|
artikel
|
| 8 |
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma
|
Fulciniti, Mariateresa
|
|
|
129 |
16 |
p. 2233-2245
|
artikel
|
| 9 |
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms
|
Tesi, Bianca
|
|
|
129 |
16 |
p. 2266-2279
|
artikel
|
| 10 |
I am SAMD9L: 7q regulator I am
|
Collin, Matthew
|
|
|
129 |
16 |
p. 2210-2212
|
artikel
|
| 11 |
Making thrombolysis safer in stroke
|
Gailani, David
|
|
|
129 |
16 |
p. 2212-2213
|
artikel
|
| 12 |
MDS with isolated del(5q) and internuclear bridging
|
Xu, Zhaodong
|
|
|
129 |
16 |
p. 2333
|
artikel
|
| 13 |
Mouse models of MLL leukemia: recapitulating the human disease
|
Milne, Thomas A.
|
|
|
129 |
16 |
p. 2217-2223
|
artikel
|
| 14 |
Multiple myeloma cells sent “PAKing”!
|
Neri, Paola
|
|
|
129 |
16 |
p. 2208-2209
|
artikel
|
| 15 |
Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke
|
Simão, Fabrício
|
|
|
129 |
16 |
p. 2280-2290
|
artikel
|
| 16 |
Published abstracts at international meetings often over- or underestimate the initial response rate
|
Beyar-Katz, Ofrat
|
|
|
129 |
16 |
p. 2326-2328
|
artikel
|
| 17 |
Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study
|
Mehta, Parinda A.
|
|
|
129 |
16 |
p. 2308-2315
|
artikel
|
| 18 |
Risk of heart failure following Hodgkin lymphoma
|
|
|
|
129 |
16 |
p. 2334
|
artikel
|
| 19 |
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines
|
van Nimwegen, Frederika A.
|
|
|
129 |
16 |
p. 2257-2265
|
artikel
|
| 20 |
Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia
|
Godwin, Colin D.
|
|
|
129 |
16 |
p. 2330-2332
|
artikel
|
| 21 |
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations
|
Branchini, Alessio
|
|
|
129 |
16 |
p. 2303-2307
|
artikel
|
| 22 |
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
|
Noy, Ariela
|
|
|
129 |
16 |
p. 2224-2232
|
artikel
|
| 23 |
The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality
|
Hill, Joshua A.
|
|
|
129 |
16 |
p. 2316-2325
|
artikel
|
Tijdschrift beschrijving